Analysts' Actions: Facebook, United Therapeutics Surge, Micron Falls

TheStreet.com

NEW YORK (TheStreet) -- Facebook  was jumping 3.7% to $57.13 after estimates and price target were raised by Cantor Fitzgerald. Shares are expected to reach $65 within 12 months, Cantor said. the shares are rated a buy.

Blackberry was falling 0.7% to $7.17 as the shares were downgraded at Hudson Square to sell from hold. $5 price target. Service revenue is falling and the company continues to burn cash, Hudson Square said.

Salesforce.com was rising 1% to $54.24 as coverage of the stock was initiated with an outperform rating at BMO Capital. $62 price target. Company is positioned well for long-term growth, BMO Capital said.

Darling was adding 1% to $20.75 as the shares were upgraded at BMO Capital to outperform. New analyst has a $25 price target. Acquisitions and JV should drive earnings growth, BMO Capital said.

[Read: Three Hits and Misses for 2014]

Five Below was jumping 3.7% to $44.30 as the shares were upgraded at Credit Suisse to outperform from neutral. $52 price target. Increasingly compelled by the combination of dollar store attributes and specialty retailer disciplines.

Fortinet was advancing 2.7% to $18.92 after being upgraded at Robert Baird to outperform from neutral. $25 price target. New CFO is a positive catalyst and the company should benefit from better security spending, Robert Baird said.

Micron was falling 3.7% to $21.35 after shares were downgraded at Bank of America/Merrill Lynch to underperform. $19.50 price target. Consensus earnings expectations appear too high, BofA/Merrill said.

United Therapeutics was surging 24% to $108.48 on an upgraded by J.P. Morgan to neutral. $90 price target. FDA approval for Orenitram was a surprise, J.P. Morgan said.

Xilinx  added 0.4% to $44.89 after shares were upgraded at Drexel Hamilton to buy from hold. $50 price target. China 4G buildout gaining momentum, Drexel Hamilton said.

[Read: Alaska Air Gets Quarterback, Ratings Upgrade]

Stock Comments / EPS Changes

Cintas
estimates, price target were increased at Credit Suisse. Shares were little changed at $59.23 Estimates were raised through 2015. Company is seeing organic growth and higher margins in all business lines, Credit Suisse said. Neutral rating and new $60 price target.

[Read: Top 10 Financial Heroes of 2013]

Finish Line  was adding 1% to $28.04 as earnings were boosted at Canaccord Genuity. Shares are now seen reaching $32. Estimates were also increased, as management has the company back on the right track, Canaccord said. Buy rating.

Follow TheStreet on Twitter and become a fan on Facebook.


EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.

View Comments (0)